Researchers at Penn State have developed soft, stretchable electrodes that closely match the human brain’s surface, potentially advancing neural interfaces for monitoring and treating neurodegenerative diseases. Unlike conventional bioelectrodes made from rigid, one-size-fits-all materials, this new approach uses 3D printing to create flexible, patient-specific sensors that adapt to individual brain structures.
Simulating the Brain for Precision Fit
To achieve this, the team used MRI-based simulations from 21 patients to design electrodes tailored to each brain’s unique folds. These folds—formed through Gyrification—create ridges (gyri) and grooves (sulci) that vary significantly between individuals. As a result, traditional electrodes often fail to fit accurately. By contrast, the new design improves compatibility and performance, as demonstrated in findings published in Advanced Materials.
Rethinking Materials and Structure
As reported by medicalxpress, the researchers built the electrodes using hydrogel, a soft, water-rich material that mimics brain tissue. Furthermore, they incorporated a honeycomb-inspired structure to enhance flexibility while maintaining strength. Consequently, this design reduces stiffness, lowers material usage, and shortens production time, making the process more cost-effective and environmentally sustainable.
From MRI to 3D-Printed Electrodes
The production process begins with an MRI scan, followed by finite element analysis to simulate the brain’s structure. The team then creates a 3D model and designs electrodes that precisely conform to the brain’s surface. Using direct ink printing, they manufacture electrodes capable of accurately monitoring neural signals. Compared to traditional fabrication methods, which require expensive cleanroom facilities, this approach enables faster and more affordable customization.
Improving Signal Quality and Safety
Importantly, the hydrogel electrodes provide softer contact with brain tissue, reducing the risk of damage. Their flexible nature ensures stable contact, leading to more reliable and higher-quality signal detection. Additionally, they do not interfere with fluid transport in the brain, a critical factor often disrupted by rigid electrodes.
Promising Results and Future Potential
In preclinical tests, the electrodes performed effectively in rat models over 28 days without triggering immune responses or performance decline. Looking ahead, researchers aim to refine this technology for disease-specific monitoring and clinical applications. Ultimately, personalized bioelectrodes could transform how clinicians diagnose and treat neurological disorders.